Relatórios

The Ethics and Health Unit (ETX) is pleased to present their latest publication.  In December 2010, ETX and the Stop TB department at WHO jointly published the guidance document 'Guidance on ethics of tuberculosis prevention, care and control'. This publication represents the fruits of the taskforce on Ethics and TB established by ETX and the Stop TB department. This document is the first of its kind and is available in English here: http://whqlibdoc.who.int/publications/2010/9789241500531_eng.pdf. It is currently being translated into the 5 other official UN languages.

Executive Summary 

This is the sixteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It pro- vides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financ- ing TB prevention, care and control at global, regional and country levels using data reported by 198 countries that account for over 99% of the world’s TB cases.

The introductory chapter (Chapter 1) provides general background on TB as well as an explanation of global targets for TB control, the WHO’s Stop TB Strategy and the Stop TB Partnership’s Global Plan to Stop TB 2011–2015. The main findings and messages about the six major themes covered in the rest of the report are pro- vided below.

Dear Colleague, 

I am pleased to send the Aeras Global TB Vaccine Foundation's 2010 Annual Report.  This multimedia report is a new format for us and we hope you will enjoy it. Throughout the report, we highlight the voices and perspectives of our many valued partners who share a common vision of a TB-free world.  

Poor progress means multidrug-resistant tuberculosis 
continues to spread and cost lives
            
Efforts to revamp international response to MDR-TB not enough 

 
New York/Geneva 7 July, 2011 – The global response to help countries scale up treatment of multidrug-resistant tuberculosis (MDR-TB) is underfunded and ineffective, according to a new report released today by three medical and medical advocacy organisations. A 20-month effort to reform the Green Light Committee Initiative, a World Health Organization (WHO)-hosted programme designed to help countries gain technical support for scale up of MDR-TB and access to quality-assured MDR-TB drugs, needs to be closely monitored to see if the reforms will address many key bottlenecks.

Attachments:

An evaluation of drug-resistant TB treatment scale-up

[ ]

1119 kB

Summary

The World Health Organization (WHO) has published an annual report on global control of tuberculosis (TB) every year since 1997. The main purpose of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic and progress made in TB care and control at global, regional and country levels. Progress towards global targets set for 2015 is given particular attention. The target included in the Millennium Development Goals (MDGs) is that TB incidence should be falling by 2015. The Stop TB Partnership has set two additional targets, which are to halve rates of prevalence and mortality by 2015 compared with their levels in 1990. Collectively, the WHO’s Stop TB Strategy and the Stop TB Partnership’s Global Plan to Stop TB have set out how the 2015 targets can be achieved.

Statement from Dr Mario Raviglione, Director, Stop TB Department

Progress in countries

Today, for World TB Day, we launch a new report Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015.

Progress is being made, but the response is far from sufficient given the MDR-TB threat facing the world. Two years on from the Beijing declaration - which was endorsed by all 27 high burden countries featured in this report - the commitments by some countries are too slow off the mark or simply stalled.

Statement from Dr Mario Raviglione, Director, Stop TB Department

Progress in countries

Today, for World TB Day, we launch a new report Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015.

Progress is being made, but the response is far from sufficient given the MDR-TB threat facing the world. Two years on from the Beijing declaration - which was endorsed by all 27 high burden countries featured in this report - the commitments by some countries are too slow off the mark or simply stalled.